₹5,193.00
+4.05 (+0.08%)
As of 17 Sept 2026, Alkem Laboratories Ltd share price is ₹5,193.00. The stock opened at ₹5,193.00 and had closed at ₹5,188.95 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹5,052.05 and a high of ₹5,933.00. In terms of performance, Alkem Laboratories Ltd share price has decreased by 2.98% over the past six months and has decreased by 5.29% over the last year.
ALKEM Stock Price Chart
Alkem Laboratories Ltd Overview
Market cap₹62,042 Crs
Volume611
Prev. Close₹5,188.95
Year range₹5,052.05 - ₹5,933.00
ISININE540L01014
About ALKEM
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical products.
Alkem Laboratories Ltd Historical Performance
1 Month Return-3.55%
6 Month Return-2.49%
3 Year Return41.12%
3 Month Return-3.00%
1 Year Return-5.78%
5 Year Return37.04%
ALKEM Futures & Options
Alkem Laboratories Ltd Fundamentals
ROCE(TTM)18.17%
P/E Ratio (TTM)28.25
P/B Ratio4.43
Debt to Equity0.04
ROE16.30%
EPS (TTM)187.45
Dividend Yield1.02%
Book Value1170.81
Profit Margin22.50%
Operating Margin22.95%
Alkem Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 10,219.08 | 9,320.50 | 8,269.84 | 9,320.84 | 9,029.70 |
| EBITDA | 2,836.47 | 2,663.26 | 1,913.34 | 1,643.24 | 2,010.25 |
| Net Profit | 2,282.09 | 2,280.89 | 1,747.15 | 1,134.47 | 1,541.25 |
| EPS | 182.76 | 190.77 | 146.13 | 94.88 | 128.90 |
Alkem Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 5,137.03 |
| Resistance 1 (R1) | 5,253.28 |
| Pivot Point | 5,201.37 |
Alkem Laboratories Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 07-Aug-2026 | 28-May-2026 | 07-Aug-2026 | Final | ₹10.00 |
| 20-Feb-2026 | 13-Feb-2026 | 20-Feb-2026 | Interim | ₹43.00 |
| 08-Aug-2025 | 29-May-2025 | 08-Aug-2025 | Final | ₹8.00 |
| 14-Feb-2025 | 07-Feb-2025 | 14-Feb-2025 | Interim | ₹37.00 |
| 09-Aug-2024 | 29-May-2024 | 10-Aug-2024 | Final | ₹5.00 |
ALKEM Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Basudeo N Singh | Chairman & Managing Director |
| SANDEEP SINGH | Managing Director |
| Mritunjay Kumar Singh | Executive Directorector |
Alkem Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,853.90+0.02% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,260.50+1.12% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,805.50-0.15% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Alkem Laboratories Ltd today is ₹5,193.00 on NSE and ₹5,193.00 on BSE.
- The 52-week high of Alkem Laboratories Ltd is ₹5,933.00, while the 52-week low is ₹5,052.05.
- The current market capitalisation of Alkem Laboratories Ltd is approximately ₹62,042 crore.
- The P/E (Price-to-Earnings) ratio of Alkem Laboratories Ltd is 26.96. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Alkem Laboratories Ltd is 4.89. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Alkem Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for ALKEM on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Alkem Laboratories Ltd has delivered a return of approximately 41.12%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Alkem Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 49.70% promoters, -6.29% FIIs, 22.63% DIIs, and 17.04% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
